Brief: Galecto Reports Second Quarter Operating And Financial Results

Damora Therapeutics

05/08/2021 14:32

Aug 5 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO REPORTS SECOND QUARTER OPERATING AND FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.49
    * GALECTO - EXPECT CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES
WILL BE SUFFICIENT TO FUND OPERATING EXPENSES, CAPITAL
REQUIREMENTS INTO H2 2024
    * COMPLETION OF ENROLLMENT IN GALACTIC-1 PHASE 2B CLINICAL
TRIAL
IN IPF PATIENTS IN 1H 2022

Source text for Eikon:  ID:nGNX4fvv2l 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))